Inviragen Inc., a Colorado based vaccine company with a research site in Madison, was purchased by Takeda Pharmaceuticals of Japan in May 2013. Takeda will pay $35 million up front and up to $215 million in milestones.
Cellara LLC is a newly formed lab equipment company focused on semi-automating cell culture processes. The company is led by Reidar Aamotsbakken and Kevin Conard.
Scilog INc. was acquired in August 2012 by Parker Hannifin Corporation, a $13 billion global supplier of motion and control technologies. SciLog will continue to operate independently in Madison under current management. The purchase price was not disclosed.
Pharmaseek LLC, pharmaseek Financial Services LLC, and Patientwise creative LLC, have been added to this database. These affiliated companies support sponsors, CROs, and academic institutions in conducting the various aspects of clinical trials.
Pan Genome systems, LLC is a newly formed company focused on developing vaccines and diagnostics for human and animal health, as well as providing select services. Founded in 2011, the company is led by CEO Adel Talaat, PhD.
kensey nash corporation announced in May 2012 that it agreed to be acquired by Royal DSM N.V. of The Netherlands for $360 million and will operate as part of its Biomedical Division.
Intuitive Biosciences, Inc. is a new company focused on diagnostic and research tools. The company was founded in March 2012, and purchased selected product lines from Gentel Biosciences, which has ceased business.
Peptimed, Inc. is a new company that purchased the assets of Nanooncology, Inc. in July 2012. NanoOncology had ceased operations earlier in the year.
aOva Technologies ceased business operations in spring 2012 and has liquidated its assets.
CareFusion agreed to sell its Madison-based Nicolet neurodiagnostic business to Natus Medical Incorporated for $58 million. The unit had sales of $95 million in 2011. Natus is a publicly traded company based in San Carlos CA. The sale was completed on July 2, 2012.
invenra inc. is a start-up company developing novel technology for peptide drug discovery. Founded by Roland Green, PhD, in 2011, the company is located in the URP at 510 Charmany Drive.
Illumavista Biosciences LLC has established operations in the University Research Park. Founded in 2010 by C. Warrren and M. Ozer, the company offers bioinformatic services and is developing microarray technology to assess protein expression.
BioSystem Development LLC was acquired in December 2011 by Agilent Technologies of Santa Clara, CA. Purchase price was not disclosed. The company continues operation in Madison under the Agilent brand.
Lifegen technologies, llc was acquired by Nu Skin Enterprises of Utah in December 2011 for $11.7 million.
Roche Madison INc. was purchased in October 2011 by Arrowhead Research Corporation, along with related RNAi intellectual property owned by Roche. Roche received a minority interest in Arrowhead, received first right to negotiate licenses on up to 8 products, and will be eligible to receive royalties and milestones. The company name has been changed to Arrowhead madison.
TRAC Microbiology announced in August 2011 that it was being purchased by Covance. Terms were undisclosed.
TREK diagnostic Systems was sold in July 2011 by Magellan Biosciences to Thermo Fisher Scientific.
EraGen Biosciences was acquired by Luminex Corporation for $34 million and continues to operate in Madison under the name Luminex Madison. The transaction closed in June 2011.
ASthmapolis was founded in 2010 to commercialize asthma related technologies. Its lead product, Spiroscout, is an GPS enabled inhaler that automatically tracks and reports its use.
SHINE MEDICAL TECHNOLOGIES was spun out from Phoenix Nuclear Labs in 2010 to commercialize its low cost production process for molybdenum-99, an isotope used in cardiovascular and cancer imaging. The company completed an $11 million financing in June 2011.
CoMMET, LLC is a company that develops multifunctional meta-materials, including tactile sensing materials that could be used in medical applications. Founded in 2009, the company was added to our database in June 2011.
Cellectar Inc. has merged with Novelos Therapeutics Inc., a public traded company. Cellectar shareholders received approximately 85% of the combined company. The new Novelos will be headquartered in Madison, with a secondary office in Boston. The company's focus will be on Cellectar's three cancer programs. Venture Investors led a concurrent $5.1 million financing.
Cellscript, Inc., formerly an affiliate of EpiCentre Biotechnologies, has been spun out as an independent company led by CEO Gary Dahl, PhD. CellScript focuses on technologies and products for translation of RNA in cells for clinical research and therapeutics.
Tomotherapy Inc. announced on March 7, 2011 that Accuray Inc. would acquire the company for $277 million in cash and stock. The transaction is expected to close in Q2. Accuray is a publicly traded radiosurgery company based in the San Francisco area. It is anticipated that R&D and manufacturing operations will continue in Madison, among other functions.
King Pharmaceuticals was acquired by Pfizer Inc. on February 28, 2011. Accordingly, the local manufacturing facility was rebranded as Pfizer Global Supply.
nerites corporation announced that Kensey Nash Corporation, a publicly traded regenerative medicine company, acquired the assets of the company on January 31, 2011 for $20 million. The Madison research site will continue under the Kensey Nash brand.
Epicentre biotechnologies announced on January 11, 2011 that it has been acquired by Illumina Inc., a leading life sciences research products company based in San Diego.
Aquamost has relocated from the Madison Enterprise Center on Baldwin Street to 103 E. Badger Road, Madison (Jan 2013)
Epicentre Biotechnologies (An Illumina Company) has relocated from its original site on Post Road to 5602 Research Park Blvd., Suite 200 in the University Research Park (Dec 2012)
Aldevron has relocated within the University Research Park to the Accelerator Building, 5602 Research Park Blvd. (Oct 2012)
Phoenix nuclear labs and shine medical technologies relocated from Middleton to 2555 Industrial Drive in Monona (May 2012)
EchoMetrix relocated to 437 S. Yellowstone Drive, Suite 210 from downtown Madison (Apr 2012)
Zurex Pharma and Zurex PharmAgra relocated from the University Research Park to 2113 Eagle Drive, Middleton. (Apr 2012)
Lucigen Corp. and c5-6 Technologies relocated within Middleton from W. Greenview Drive to a 28,000 square foot facility at 2905 Parmenter Street. (Apr 2012)
SCILOG relocated to 801 Deming Way Madison from 8845 S. Greenview Drive Middleton (Mar 2012)